As of April 16, 2025, Hualan Biological Engineering (002007.SZ) has a market cap of $4.02 billion USD. According to our data, Hualan Biological Engineering is ranked No.2891 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $4.02 B |
-4.53%
|
Dec 31, 2024 | $4.21 B |
-22.52%
|
Dec 29, 2023 | $5.44 B |
-0.87%
|
Dec 30, 2022 | $5.48 B |
-21.57%
|
Dec 31, 2021 | $6.99 B |
-30.45%
|
Dec 31, 2020 | $10.06 B |
57.89%
|
Dec 31, 2019 | $6.37 B |
62.30%
|
Dec 28, 2018 | $3.92 B |
23.17%
|
Dec 29, 2017 | $3.19 B |
-23.98%
|
Dec 30, 2016 | $4.19 B |
31.04%
|
Dec 31, 2015 | $3.20 B |
33.42%
|
Dec 31, 2014 | $2.40 B |
17.86%
|
Dec 31, 2013 | $2.03 B |
36.96%
|
Dec 31, 2012 | $1.48 B |
-15.48%
|
Dec 30, 2011 | $1.76 B |
-47.85%
|
Dec 31, 2010 | $3.37 B |
40.07%
|
Dec 31, 2009 | $2.40 B |
131.39%
|
Dec 31, 2008 | $1.04 B |
-27.75%
|
Dec 28, 2007 | $1.44 B |
234.86%
|
Dec 29, 2006 | $0.43 B |
233.12%
|
Dec 30, 2005 | $0.13 B |
-7.83%
|
Dec 31, 2004 | $0.14 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() CSL
CSL.AX
|
$74.79 B |
-0.212 B
|
![]() Australia
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Dynavax Technologies
DVAX
|
$1.42 B |
-0.000 M
|
![]() USA
|
![]() Inovio Pharmaceuticals
INO
|
$64.55 M |
0.000 M
|
![]() USA
|
![]() Vaxart
VXRT
|
$81.11 M |
-0.000 M
|
![]() USA
|
Market Cap | = | 002007.SZ Stock Price | * | 002007.SZ Shares Outstanding |
= | $2.19 | * | 1.83 B | |
= | $4.02 B |